A citation-based method for searching scientific literature

Lekha Mikkilineni, James N Kochenderfer. Nat Rev Clin Oncol 2021
Times Cited: 73







List of co-cited articles
618 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The Mechanism of Action of the Anti-CD38 Monoclonal Antibody Isatuximab in Multiple Myeloma.
Laura Moreno, Cristina Perez, Aintzane Zabaleta, Irene Manrique, Diego Alignani, Daniel Ajona, Laura Blanco, Marta Lasa, Patricia Maiso, Idoia Rodriguez,[...]. Clin Cancer Res 2019
113
1

Integrated Pharmacokinetic/Pharmacodynamic Model of a Bispecific CD3xCD123 DART Molecule in Nonhuman Primates: Evaluation of Activity and Impact of Immunogenicity.
Olivia Campagne, Audrey Delmas, Sylvain Fouliard, Marylore Chenel, Gurunadh R Chichili, Hua Li, Ralph Alderson, Jean-Michel Scherrmann, Donald E Mager. Clin Cancer Res 2018
41
2

Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform.
Muneera Al-Hussaini, Michael P Rettig, Julie K Ritchey, Darja Karpova, Geoffrey L Uy, Linda G Eissenberg, Feng Gao, William C Eades, Ezio Bonvini, Gurunadh R Chichili,[...]. Blood 2016
115
1

Differential expression of CD3 and CD7 in T-cell malignancies: a quantitative study by flow cytometry.
L Ginaldi, E Matutes, N Farahat, M De Martinis, R Morilla, D Catovsky. Br J Haematol 1996
71
1

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.
Moshe Sade-Feldman, Keren Yizhak, Stacey L Bjorgaard, John P Ray, Carl G de Boer, Russell W Jenkins, David J Lieb, Jonathan H Chen, Dennie T Frederick, Michal Barzily-Rokni,[...]. Cell 2019
97
1

Identification and characterization of an active soluble form of human CD38 in normal and pathological fluids.
A Funaro, A L Horenstein, L Calosso, M Morra, R P Tarocco, L Franco, A De Flora, F Malavasi. Int Immunol 1996
73
1

BioNetGen 2.2: advances in rule-based modeling.
Leonard A Harris, Justin S Hogg, José-Juan Tapia, John A P Sekar, Sanjana Gupta, Ilya Korsunsky, Arshi Arora, Dipak Barua, Robert P Sheehan, James R Faeder. Bioinformatics 2016
93
1

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas.
Zohreh Amoozgar, Jonas Kloepper, Jun Ren, Rong En Tay, Samuel W Kazer, Evgeny Kiner, Shanmugarajan Krishnan, Jessica M Posada, Mitrajit Ghosh, Emilie Mamessier,[...]. Nat Commun 2021
28
3

Multiple Myeloma Cells Express Key Immunoregulatory Cytokines and Modulate the Monocyte Migratory Response.
Leonardo Freire-de-Lima, Ana Flávia Fernandes Ribas Nardy, Erivan Schnaider Ramos-Junior, Luciana Conde, Jéssica Santos Lemos, Leonardo Marques da Fonseca, Juliana Echevarria Lima, Angelo Maiolino, Alexandre Morrot. Front Med (Lausanne) 2017
6
16

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody.
Ralf Bargou, Eugen Leo, Gerhard Zugmaier, Matthias Klinger, Mariele Goebeler, Stefan Knop, Richard Noppeney, Andreas Viardot, Georg Hess, Martin Schuler,[...]. Science 2008
718
1

Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles.
Ying-Chun Lo, Michael A Edidin, Jonathan D Powell. J Immunol 2013
15
6



Nanobody-based dual epitopes protein identification (DepID) assay for measuring soluble CD38 in plasma of multiple myeloma patients.
Ting Li, Song Lu Li, Cheng Fang, Yun Nan Hou, Qiaoxia Zhang, Xin Du, Hon Cheung Lee, Yong Juan Zhao. Anal Chim Acta 2018
7
14


Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Peng Jiang, Shengqing Gu, Deng Pan, Jingxin Fu, Avinash Sahu, Xihao Hu, Ziyi Li, Nicole Traugh, Xia Bu, Bo Li,[...]. Nat Med 2018
1

T cell responses: naive to memory and everything in between.
Nathan D Pennock, Jason T White, Eric W Cross, Elizabeth E Cheney, Beth A Tamburini, Ross M Kedl. Adv Physiol Educ 2013
215
1

Quantification of number of CD38 sites on bone marrow plasma cells in patients with light chain amyloidosis and smoldering multiple myeloma.
Katharina Kriegsmann, Tobias Dittrich, Brigitte Neuber, Mohamed H S Awwad, Ute Hegenbart, Hartmut Goldschmidt, Jens Hillengass, Dirk Hose, Anja Seckinger, Carsten Müller-Tidow,[...]. Cytometry B Clin Cytom 2018
9
11

Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agents.
Xiling Jiang, Xi Chen, Thomas J Carpenter, Jun Wang, Rebecca Zhou, Hugh M Davis, Donald L Heald, Weirong Wang. MAbs 2018
23
4

Upregulation of CD38 expression on multiple myeloma cells by all-trans retinoic acid improves the efficacy of daratumumab.
I S Nijhof, R W J Groen, H M Lokhorst, B van Kessel, A C Bloem, J van Velzen, R de Jong-Korlaar, H Yuan, W A Noort, S K Klein,[...]. Leukemia 2015
169
1

Characterization of in vitro growth of multiple myeloma cells.
Mihaela Zlei, Sabine Egert, Dagmar Wider, Gabriele Ihorst, Ralph Wäsch, Monika Engelhardt. Exp Hematol 2007
33
3

A QSP Model for Predicting Clinical Responses to Monotherapy, Combination and Sequential Therapy Following CTLA-4, PD-1, and PD-L1 Checkpoint Blockade.
Oleg Milberg, Chang Gong, Mohammad Jafarnejad, Imke H Bartelink, Bing Wang, Paolo Vicini, Rajesh Narwal, Lorin Roskos, Aleksander S Popel. Sci Rep 2019
36
2

Origin and differentiation of human memory CD8 T cells after vaccination.
Rama S Akondy, Mark Fitch, Srilatha Edupuganti, Shu Yang, Haydn T Kissick, Kelvin W Li, Ben A Youngblood, Hossam A Abdelsamed, Donald J McGuire, Kristen W Cohen,[...]. Nature 2017
261
1

Overview of the immune response.
David D Chaplin. J Allergy Clin Immunol 2010
701
1


A methodology for performing global uncertainty and sensitivity analysis in systems biology.
Simeone Marino, Ian B Hogue, Christian J Ray, Denise E Kirschner. J Theor Biol 2008
894
1

Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy.
Jinyang Li, Katelyn T Byrne, Fangxue Yan, Taiji Yamazoe, Zeyu Chen, Timour Baslan, Lee P Richman, Jeffrey H Lin, Yu H Sun, Andrew J Rech,[...]. Immunity 2018
302
1

Circulating plasma cells in multiple myeloma: characterization and correlation with disease stage.
A C Rawstron, R G Owen, F E Davies, R J Johnson, R A Jones, S J Richards, P A Evans, J A Child, G M Smith, A S Jack,[...]. Br J Haematol 1997
148
1

Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells.
Anja Feldmann, Claudia Arndt, Katrin Töpfer, Slava Stamova, Franziska Krone, Marc Cartellieri, Stefanie Koristka, Irene Michalk, Dirk Lindemann, Marc Schmitz,[...]. J Immunol 2012
74
1



Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma.
Laura R Díaz, Elena Saavedra-López, Leire Romarate, Izaskun Mitxitorena, Paola V Casanova, George P Cribaro, José M Gallego, Ana Pérez-Vallés, Jerónimo Forteza-Vila, Clara Alfaro-Cervello,[...]. JCI Insight 2018
9
11

Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer.
T Saito, I Kuss, G Dworacki, W Gooding, J T Johnson, T L Whiteside. Clin Cancer Res 1999
90
1

CD33 target validation and sustained depletion of AML blasts in long-term cultures by the bispecific T-cell-engaging antibody AMG 330.
Christina Krupka, Peter Kufer, Roman Kischel, Gerhard Zugmaier, Jan Bögeholz, Thomas Köhnke, Felix S Lichtenegger, Stephanie Schneider, Klaus H Metzeler, Michael Fiegl,[...]. Blood 2014
125
1

Modulation of CD28 expression with anti-tumor necrosis factor alpha therapy in rheumatoid arthritis.
Ewa Bryl, Abbe N Vallejo, Eric L Matteson, Jacek M Witkowski, Cornelia M Weyand, Jorg J Goronzy. Arthritis Rheum 2005
100
1

Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model.
Huilin Ma, Hanwen Wang, Richard J Sové, Jun Wang, Craig Giragossian, Aleksander S Popel. J Immunother Cancer 2020
16
6

Prolonged exposure of naïve CD8+ T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length.
Diana L Wallace, Marion Bérard, Maria V D Soares, Janine Oldham, Joanne E Cook, Arne N Akbar, David F Tough, Peter C L Beverley. Immunology 2006
61
1


Using network biology to bridge pharmacokinetics and pharmacodynamics in oncology.
D C Kirouac, M D Onsum. CPT Pharmacometrics Syst Pharmacol 2013
23
4


Unprimed CD4+ and CD8+ T cells can be rapidly activated by a CD3 x CD19 bispecific antibody to proliferate and become cytotoxic.
I A Haagen, W B de Lau, B J Bast, A J Geerars, M R Clark, B C de Gast. Cancer Immunol Immunother 1994
20
5

Red blood cell distribution width: A simple parameter with multiple clinical applications.
Gian Luca Salvagno, Fabian Sanchis-Gomar, Alessandra Picanza, Giuseppe Lippi. Crit Rev Clin Lab Sci 2015
414
1

Inflammation and cancer.
Lisa M Coussens, Zena Werb. Nature 2002
1

[Pathogenesis of multiple myeloma].
L Rasche, N Weinhold. Internist (Berl) 2019
3
33

Current use of monoclonal antibodies in the treatment of multiple myeloma.
Cindy Varga, Michelle Maglio, Irene M Ghobrial, Paul G Richardson. Br J Haematol 2018
24
4

Red blood cell distribution width (RDW) and long-term survival in patients with ST elevation myocardial infarction.
Yaron Arbel, Yacov Shacham, Ariel Finkelstein, Amir Halkin, Assi Milwidsky, Shlomo Berliner, Tomer Ziv-Baran, Miri Revivo, Itzhak Herz, Gad Keren,[...]. Thromb Res 2014
29
3

Pre-treatment red blood cell distribution width provides prognostic information in multiple myeloma.
Di Zhou, Peipei Xu, Miaoxin Peng, Xiaoyan Shao, Miao Wang, Jian Ouyang, Bing Chen. Clin Chim Acta 2018
9
11

Proinflammatory state and circulating erythropoietin in persons with and without anemia.
Luigi Ferrucci, Jack M Guralnik, Richard C Woodman, Stefania Bandinelli, Fulvio Lauretani, Anna Maria Corsi, Paulo H M Chaves, William B Ershler, Dan L Longo. Am J Med 2005
136
1

Red cell distribution width (RDW): a prognostic indicator of severe COVID-19.
Changzheng Wang, Hongmei Zhang, Xiaocui Cao, Rongrong Deng, Yi Ye, Zhongxiao Fu, Liyao Gou, Feng Shao, Jin Li, Weiyang Fu,[...]. Ann Transl Med 2020
25
4



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.